Presented by – Stefan Muench, Business Director Validation, Körber Pharma Consulting Key Learning Points: Technology Trigger: FDA’s case for quality initiativePeak of Inflated Expectations: VaporwareTrough of Disillusionment: A ghosting guidanceSlope of Enlightenment: Hide and seek – CSA in G5SEPlateau of Productivity: Reserved for future use Key Takeaways: What are the drivers behind CSA?How CSA permeated […]
To access this post, you must purchase MEMBER PLUS +.